These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 1635125

  • 1. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
    Lin JS, Lui SM, Chen CM, Chang WC.
    J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
    [Abstract] [Full Text] [Related]

  • 2. The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
    Lin JS, Chang WC, Lui SM.
    Proc Natl Sci Counc Repub China B; 1994 Jan; 18(1):12-6. PubMed ID: 8029369
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous measurements of prostacyclin and thromboxane metabolites during the menstrual cycle.
    Presser SC, Stanczyk FZ, Lobo RA.
    Am J Obstet Gynecol; 1991 Sep; 165(3):647-51. PubMed ID: 1892191
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
    Kurki T, Viinikka L, Ylikorkala O.
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prostacyclin-to-thromboxane A2 ratio in arteriogenic impotence.
    Kim SC, Choi IG, Oh CH, Cha YJ.
    J Urol; 1990 Dec; 144(6):1373-5. PubMed ID: 2231931
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children.
    Leonhardt A, Busch C, Schweer H, Seyberth HW.
    Acta Paediatr; 1992 Mar; 81(3):191-6. PubMed ID: 1511190
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM, Jung JK, Kim SJ, Viinikka LU, Ylikorkala RO.
    Cancer Res; 1991 Aug 15; 51(16):4146-8. PubMed ID: 1868436
    [Abstract] [Full Text] [Related]

  • 10. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
    Mizugaki M, Hishinuma T, Matsumura E, Murai Y, Yamazaki T, Yamanobe S, Tamai M.
    Prostaglandins Other Lipid Mediat; 1999 Nov 15; 58(5-6):253-62. PubMed ID: 10593167
    [Abstract] [Full Text] [Related]

  • 11. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C, Pinciroli V, Campoleoni A, Benigni A, Piccinelli A, Fanelli R.
    J Chromatogr; 1989 Oct 27; 495():1-11. PubMed ID: 2613794
    [Abstract] [Full Text] [Related]

  • 12. Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension.
    Ichida F, Uese K, Hamamichi Y, Hashimoto I, Tsubata S, Fukahara K, Murakami A, Miyawaki T.
    Acta Paediatr Jpn; 1998 Feb 27; 40(1):14-9. PubMed ID: 9583194
    [Abstract] [Full Text] [Related]

  • 13. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H, Hirai A, Terano T, Tamura Y, Yoshida S.
    Thromb Haemost; 1993 Mar 01; 69(3):276-81. PubMed ID: 8470052
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
    Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE.
    N Engl J Med; 1992 Jul 09; 327(2):70-5. PubMed ID: 1603138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
    Rauramo I, Ilmonen S, Viinikka L, Ylikorkala O.
    Obstet Gynecol; 1995 Jun 09; 85(6):1027-30. PubMed ID: 7770249
    [Abstract] [Full Text] [Related]

  • 19. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
    Tohgi H, Konno S, Tamura K, Kimura B, Kawano K.
    Stroke; 1992 Oct 09; 23(10):1400-3. PubMed ID: 1412574
    [Abstract] [Full Text] [Related]

  • 20. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O, Kuusi T, Tikkanen MJ, Viinikka L.
    J Clin Endocrinol Metab; 1987 Dec 09; 65(6):1238-42. PubMed ID: 2960690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.